HR 383

  • House Bill
  • 118th Congress
  • Introduced in House Jan 17, 2023
  • House
  • Senate
  • Governor

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Votes


No votes to display

Actions


Jan 27, 2023

House

Referred to the Subcommittee on Health.

Jan 17, 2023

House

Referred to the House Committee on Energy and Commerce.

House

Introduced in House

Bill Text

Bill Text Versions Format
Introduced in House PDF XML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the US Congress.

If you notice any inconsistencies with these official sources, feel free to file an issue.